Trials / Not Yet Recruiting
Not Yet RecruitingNCT07231315
INTERACT4 Expansion - Validation Study
INTEnsive Ambulance-delivered Blood Pressure Reduction in Biomarker-identified Hyper-ACute Intracerebral Haemorrhage Trial - Validation Study
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 465 (estimated)
- Sponsor
- The George Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
As an investigator-initiated and conducted, multi-centre, open-label, single-arm prospective observational trial, INTERACT4 Expansion aims to evaluate the diagnostic accuracy of GFAP measured using a point-of-care device, for identifying ICH in participants presenting with acute stroke-like symptoms in the pre-hospital setting compared with imaging-confirmed ICH.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | LVOne | LVOne is an in vitro diagnostic rapid lateral flow chromatographic immunoassay kit |
Timeline
- Start date
- 2026-02-01
- Primary completion
- 2026-11-01
- Completion
- 2027-06-01
- First posted
- 2025-11-17
- Last updated
- 2025-11-19
Locations
4 sites across 1 country: Australia
Source: ClinicalTrials.gov record NCT07231315. Inclusion in this directory is not an endorsement.